Collaboration and convergence across science and technology are creating wondrous possibilities for treating patients. Therapeutic advances in the lab enhanced by digital applications present interesting and novel challenges to IP practitioners tasked with figuring out how best to protect these innovations. This workshop will discuss how US case law is developing to address the evolving landscape in the life sciences, prosecution strategies in the digital health arena, and an update regarding what is happening at the recently opened Unified Patent Court (UPC). If there is a topic you would like addressed, let us know.
Join us for an engaging conversation and practical strategy regarding:
• The UPC’s First Months and Its Impact on Life Sciences Litigation
• An Update on Recent Impactful Court Decisions and What They Mean for Practitioners
• Building Strong IP Portfolios in Digital Health
• Panel Discussion: What’s Exciting and What’s Challenging About the Current IP Landscape in Life Sciences/MedTech
If you will be joining us in-person, in addition to the registration confirmation with webinar details, you will receive a separate confirmation from Finnegan with location details
Who Should Attend: General counsel and corporate patent counsel with responsibility for/interest in protecting a company’s intellectual property.
MCLE Credit: Finnegan confirms that this activity has been certified for 2.25 hours of California MCLE.
Registration: There is no charge to attend, and space is limited. Please register by Wednesday, October 18.
Time (PDT):
2:00-2:15 p.m. Registration
2:15-4:45 p.m. Program
4:45-6:00 p.m. Reception (in-person only)